Patients treated with anti-tumor drugs displaying neurological deficits are characterized by a low circulating level of nerve growth factor.

Academic Article
Publication Date:
2000
Iris type:
01.01 Articolo in rivista
List of contributors:
Authors of the University:
Handle:
https://iris.cnr.it/handle/20.500.14243/162879
Published in:
CLINICAL CANCER RESEARCH (PRINT)
Journal